Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson symbols : EBS save search
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 0.0%
H: 0.15%
C: -7.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
LQDA M | $13.31 -3.62% -3.76% 830K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -1.74%
Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600
Published: 2023-08-21 (Crawled : 22:00) - prnewswire.com
KVUE 4 | $19.58 0.72% 9.5M
|
n/a
|
| O: 1.48%
H: 2.5%
C: 2.15%
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: 0.64%
H: 1.22%
C: 0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -8.19%
H: 3.09%
C: 2.52%
DLB | $78.18 -0.14% 0.0% 260K
|
Consumer Services
|
| O: -0.02%
H: 0.56%
C: -2.91%
AAP | $78.69 1.93% 0.0% 1.7M
|
Retail Trade
|
| O: -1.76%
H: 1.6%
C: 0.51%
set
Global Vaccines Market Research Report 2022-2027: A $200+ Billion Industry - Forecasts, Company Market Share and Expert Market Estimates for Vaccine Categories
Published: 2023-02-08 (Crawled : 16:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.09%
H: 1.26%
C: 0.99%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.06%
H: 0.77%
C: 0.19%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.78%
H: 0.79%
C: -5.29%
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: -0.07%
H: 4.9%
C: 2.27%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.0%
H: 1.74%
C: -4.13%
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: -1.61%
H: 2.73%
C: -8.47%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.35%
H: 1.53%
C: 0.68%
research global report vaccine market
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
financial results solutions report results merge
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.35%
C: -0.32%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 1.66%
H: 2.7%
C: -1.54%
covid vaccine merge covid-19
EMERGENT BIOSOLUTIONS 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Emergent BioSolutions Inc. - EBS
Published: 2021-06-17 (Crawled : 00:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.18%
H: 0.56%
C: -0.79%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.51%
H: 1.33%
C: -3.58%
merge
EBS Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or June 18, 2021 Deadline in Securities Fraud Class Action Lawsuit
Published: 2021-06-14 (Crawled : 15:15) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.28%
H: 0.58%
C: 0.53%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 0.11%
H: 0.63%
C: -2.82%
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson’s Emergency Use Authorization
Published: 2021-06-11 (Crawled : 21:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
covid vaccine drug merge authorized emergency use authorization
Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
Published: 2021-06-08 (Crawled : 19:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.37%
H: 1.09%
C: 0.98%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 1.11%
H: 1.69%
C: 0.68%
merge
Kessler Topaz Meltzer & Check, LLP Files A Shareholder Class Action Lawsuit Against Emergent Biosolutions Inc. (NYSE: EBS) For Violations Of Federal Securities Laws With Expanded Class Period
Published: 2021-05-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.13%
H: 0.52%
C: -2.63%
merge
Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Emergent BioSolutions Inc. Investors of Securities Fraud Class Action Lawsuit
Published: 2021-05-12 (Crawled : 22:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.73%
H: 2.23%
C: 1.79%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 0.73%
H: 1.49%
C: -0.9%
merge
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)
Published: 2021-05-07 (Crawled : 17:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.52%
C: 0.12%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 0.92%
H: 1.77%
C: 0.34%
merge
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.
Published: 2021-05-01 (Crawled : 00:20) - prnewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
merge
Statement on Issuance of Form FDA 483 at Emergent Bayview Facility
Published: 2021-04-21 (Crawled : 17:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.49%
H: 2.19%
C: 1.07%
fda merge
Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments; Receives Modified Task Order from the U.S. Department of Health & Human Services to Support the Opportunity for Further Expansion of Manufacturing Capacity for Johnson & Johnson’s COVID-19 Vaccine
Published: 2021-04-05 (Crawled : 03:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.5%
H: 0.68%
C: -0.13%
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: -0.53%
H: 0.11%
C: -1.76%
covid expansion contract vaccine merge order
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.